Monopar Therapeutics Cash Flow Statement 2017-2024 | MNPR

Fifteen years of historical annual cash flow statements for Monopar Therapeutics (MNPR).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020201920182017
$-8.40$-10.52$-9.10$-6.30$-4.22$-3.23$-16.55
$0$0$0$0$0$0$0
$1.90$1.64$1.47$1.20$1.01$0.53$13.81
$1.90$1.64$1.47$1.20$1.01$0.53$13.81
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$-0.02$0.17$-0.09$0.00$-0.05$-0.07$-0.13
$-1.35$1.65$0.32$0.44$0.20$0.02$0.12
$-7.86$-7.23$-7.32$-4.66$-3.02$-2.68$-2.63
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$4.93$-4.92$0$0$0$0$0
$0$0$0$0$0$0$0
$4.93$-4.92$0$0$0$0$0
$0$0$0$0$0$0$0
$4.93$-4.92$0$0$0$0$0
$0$0$0$0.12$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0.12$0$0$0
$2.07$0.11$10.94$8.18$10.33$0$4.71
$2.07$0.11$10.94$8.18$10.33$0$4.71
$0$0$0$0$0$0$0
$-0.05$-0.08$-0.06$-0.12$-0.98$-0.21$4.83
$2.03$0.03$10.88$8.18$9.35$-0.21$9.54
$-0.92$-12.12$3.57$3.52$6.32$-2.89$6.91
$1.90$1.64$1.47$1.32$1.01$0.53$0.31
$0$0$0$0$0$0$0